Bioasis Technologies Inc.
BIOAF · OTC
2/28/2022 | 2/28/2021 | 2/28/2020 | 2/28/2019 | |
|---|---|---|---|---|
| Market Cap | $19,102 | $26,597 | $14,609 | $24,676 |
| - Cash | $1,731 | $2,737 | $576 | $1,360 |
| + Debt | $1,902 | $114 | $1,004 | $0 |
| Enterprise Value | $19,273 | $23,974 | $15,036 | $23,316 |
| Revenue | $38 | $4,078 | $606 | $1,422 |
| % Growth | -99.1% | 572.5% | -57.4% | – |
| Gross Profit | -$1,188 | $2,840 | $606 | $1,412 |
| % Margin | -3,150.2% | 69.6% | 100% | 99.3% |
| EBITDA | -$3,542 | $438 | -$4,536 | -$4,790 |
| % Margin | -9,388.6% | 10.7% | -748% | -336.8% |
| Net Income | -$2,960 | $698 | -$4,056 | -$3,473 |
| % Margin | -7,846.5% | 17.1% | -669% | -244.3% |
| EPS Diluted | -0.041 | 0.01 | -0.065 | -0.061 |
| % Growth | -498.1% | 115.8% | -6.2% | – |
| Operating Cash Flow | -$3,636 | $1,771 | -$3,299 | -$3,230 |
| Capital Expenditures | $0 | $0 | $0 | -$2 |
| Free Cash Flow | -$3,636 | $1,771 | -$3,299 | -$3,232 |